Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 27;56(1):143.
doi: 10.1007/s12029-025-01267-z.

Pretreatment Skeletal Muscle Index and Survival Outcomes in Non-Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Clifford Atuiri  1 , Isaac Che Ngang  2 , Daniel Appiah  2 , Armel Landry Batchi-Bouyou  2 , Kayode Ademola Matthew  2 , Abel Zemedkun Girma  3 , Lawrence Sentongo Katumba  4 , Leslie Tasha Mbapah  5 , Semere Bekena  2
Affiliations
Review

Pretreatment Skeletal Muscle Index and Survival Outcomes in Non-Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Clifford Atuiri et al. J Gastrointest Cancer. .

Abstract

Background: Skeletal muscle index (SMI), a measure of muscle mass derived from pretreatment imaging, has emerged as a potential prognostic factor in cancer. Its role in non-metastatic colorectal cancer (CRC), where curative treatment is possible, remains underexplored.

Purpose: To evaluate the association between pretreatment SMI and survival outcomes, specifically overall survival (OS) and disease-free survival (DFS), in patients with non-metastatic CRC through a systematic review and meta-analysis.

Methods: We searched PubMed, Embase, SCOPUS, Web of Science, Cochrane Library, and ClinicalTrials.gov from inception to March 24, 2025, for studies reporting SMI (measured via CT scan at L3) and survival outcomes in non-metastatic CRC. Studies were assessed for quality using the Newcastle-Ottawa Scale (NOS). Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using a random-effects model. Heterogeneity was evaluated with the I2 statistic.

Results: Seventeen studies, comprising 16,031 patients, were included. Low SMI was associated with a 28% higher risk of overall mortality (pooled HR for OS: 1.28, 95% CI: 1.04-1.57, p = 0.02) and a 23% higher risk of recurrence/progression (pooled HR for DFS: 1.23, 95% CI: 1.02-1.49, p = 0.02). Heterogeneity was high reflecting variability in SMI cutoffs and study designs.

Conclusion: Low pretreatment SMI is a significant predictor of poorer OS and DFS in non-metastatic CRC. Its routine assessment via existing CT scans could enhance risk stratification and guide interventions to improve outcomes. High study heterogeneity warrants further research to standardize measurement thresholds and clarify its clinical utility.

Keywords: Body composition; Colon cancer; Colorectal cancer; Sarcopenia; Skeletal muscle index; Survival.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: This a systematic review and meta-analysis of already published studies. No ethical approval was required. Competing interests: The authors declare no competing interests.

References

    1. Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut [Internet]. 2023 [cited 2025 Mar 21];72(2):338–44. Available from: https://pubmed.ncbi.nlm.nih.gov/36604116/ .
    1. Colorectal cancer [Internet]. [cited 2025 Mar 21]. Available from: https://www.who.int/news-room/fact-sheets/detail/colorectal-cancer .
    1. Agrawal N, Lanjhiyana SK, Jaiswal M, Siddiqui MA, Gupta S. Colorectal cancer spectrum: From subtypes and epidemiology to oncotherapies. Gastroenterology & Endoscopy. 2025;3(2):55–64. - DOI
    1. Jung M, Diallo TD, Scheef T, Reisert M, Rau A, Russe MF, et al. Association Between Body Composition and Survival in Patients With Gastroesophageal Adenocarcinoma: An Automated Deep Learning Approach. JCO Clin Cancer Inform [Internet]. 2024 Apr [cited 2025 Mar 22];(8). Available from: https://doi.org/10.1200/CCI.23.00231 .
    1. Giri S, Harmon C, Hess D, Cespedes Feliciano EM, Fumagalli IA, Caan B, et al. CT-Based Body Composition and Frailty as Predictors of Survival Among Older Adults With Gastrointestinal Malignancies. J Cachexia Sarcopenia Muscle [Internet]. 2025 Feb 1 [cited 2025 Mar 22];16(1):e13664. Available from: https://doi.org/10.1002/jcsm.13664 .

LinkOut - more resources